Strensiq (Alexion Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Strensiq drug offered from Alexion Pharmaceuticals Inc.. This Tissue-nonspecific Alkaline Phosphatase [EPC],Alkaline Phosphatase [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alexion Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | asfotase alfa |
| SUBSTANCE NAME: | ASFOTASE ALFA |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Tissue-nonspecific Alkaline Phosphatase [EPC],Alkaline Phosphatase [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-10-23 |
| END MARKETING DATE: | 0000-00-00 |
Strensiq HUMAN PRESCRIPTION DRUG Details:
| Item Description | Strensiq from Alexion Pharmaceuticals Inc. |
| LABELER NAME: | Alexion Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 18(mg/.45mL) |
| START MARKETING DATE: | 2015-10-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 25682-010_82e667d9-dbd1-40df-8a25-10f6e3e58c82 |
| PRODUCT NDC: | 25682-010 |
| APPLICATION NUMBER: | BLA125513 |
Other ASFOTASE ALFA Pharmaceutical Manufacturers / Labelers:
